Vitamin E Functions by Association with a Novel Binding Site on the 67 kDa Laminin Receptor Activating Diacylglycerol Kinase.

[1]  H. Ashida,et al.  The mechanisms of ameliorating effect of a green tea polyphenol on diabetic nephropathy based on diacylglycerol kinase α , 2020, Scientific Reports.

[2]  Jie Zheng,et al.  Recommendations for performing, interpreting and reporting hydrogen deuterium exchange mass spectrometry (HDX-MS) experiments , 2019, Nature Methods.

[3]  J. Mccammon,et al.  Membrane Allostery and Unique Hydrophobic Sites Promote Enzyme Substrate Specificity , 2018, Journal of the American Chemical Society.

[4]  H. Ashida,et al.  Amelioration of diabetic nephropathy by oral administration of d-α-tocopherol and its mechanisms , 2018, Bioscience, biotechnology, and biochemistry.

[5]  Y. Shirai,et al.  Effects of vitamin E and its derivatives on diabetic nephropathy in Rats and identification of diacylglycerol kinase subtype involved in the improvement of diabetic nephropathy , 2017 .

[6]  M. Topham,et al.  Diacylglycerol Kinase alpha is Involved in the Vitamin E-Induced Amelioration of Diabetic Nephropathy in Mice , 2017, Scientific Reports.

[7]  J Andrew McCammon,et al.  Computer-aided drug design guided by hydrogen/deuterium exchange mass spectrometry: A powerful combination for the development of potent and selective inhibitors of Group VIA calcium-independent phospholipase A2. , 2016, Bioorganic & medicinal chemistry.

[8]  D. Meruelo,et al.  Looking into laminin receptor: critical discussion regarding the non‐integrin 37/67‐kDa laminin receptor/RPSA protein , 2016, Biological reviews of the Cambridge Philosophical Society.

[9]  Varnavas D. Mouchlis,et al.  Development of Potent and Selective Inhibitors for Group VIA Calcium-Independent Phospholipase A2 Guided by Molecular Dynamics and Structure-Activity Relationships. , 2016, Journal of medicinal chemistry.

[10]  Alexander D. MacKerell,et al.  CHARMM-GUI Input Generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM Simulations Using the CHARMM36 Additive Force Field , 2015, Journal of chemical theory and computation.

[11]  C. P. Winlove,et al.  α-Tocopherols modify the membrane dipole potential leading to modulation of ligand binding by P-glycoprotein , 2015, Journal of Lipid Research.

[12]  H. Ashida,et al.  Epigallocatechin-3-gallate activates diacylglycerol kinase alpha via a 67 kDa laminin receptor: A possibility of galloylated catechins as functional food to prevent and/or improve diabetic renal dysfunctions , 2015 .

[13]  H. Loh,et al.  Cytotoxicity and apoptotic activities of alpha-, gamma- and delta-tocotrienol isomers on human cancer cells , 2014, BMC Complementary and Alternative Medicine.

[14]  Sunhwan Jo,et al.  CHARMM‐GUI Membrane Builder toward realistic biological membrane simulations , 2014, J. Comput. Chem..

[15]  Koji Yamada,et al.  67-kDa Laminin Receptor-dependent Protein Phosphatase 2A (PP2A) Activation Elicits Melanoma-specific Antitumor Activity Overcoming Drug Resistance* , 2014, The Journal of Biological Chemistry.

[16]  Guang-xun Li,et al.  Cancer prevention by tocopherols and tea polyphenols. , 2013, Cancer letters.

[17]  Woody Sherman,et al.  Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments , 2013, Journal of Computer-Aided Molecular Design.

[18]  K. Sugihara,et al.  67-kDa laminin receptor increases cGMP to induce cancer-selective apoptosis. , 2013, The Journal of clinical investigation.

[19]  K. Sugihara,et al.  Green Tea Polyphenol EGCG Sensing Motif on the 67-kDa Laminin Receptor , 2012, PloS one.

[20]  Alexander D. MacKerell,et al.  Update of the CHARMM all-atom additive force field for lipids: validation on six lipid types. , 2010, The journal of physical chemistry. B.

[21]  Alexander D. MacKerell,et al.  CHARMM general force field: A force field for drug‐like molecules compatible with the CHARMM all‐atom additive biological force fields , 2009, J. Comput. Chem..

[22]  S. Lemaire-Ewing,et al.  7-Ketocholesterol Incorporation into Sphingolipid/Cholesterol-enriched (Lipid Raft) Domains Is Impaired by Vitamin E , 2009, The Journal of Biological Chemistry.

[23]  J. Crowley,et al.  Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). , 2009, JAMA.

[24]  Virgil L. Woods,et al.  A Phospholipid Substrate Molecule Residing in the Membrane Surface Mediates Opening of the Lid Region in Group IVA Cytosolic Phospholipase A2* , 2008, Journal of Biological Chemistry.

[25]  Y. Fujimura,et al.  The impact of the 67kDa laminin receptor on both cell-surface binding and anti-allergic action of tea catechins. , 2008, Archives of biochemistry and biophysics.

[26]  S. Hubbard,et al.  Crystal Structure of the Human Laminin Receptor Precursor* , 2008, Journal of Biological Chemistry.

[27]  Koji Yamada,et al.  Green Tea Polyphenol Epigallocatechin-3-gallate Signaling Pathway through 67-kDa Laminin Receptor* , 2008, Journal of Biological Chemistry.

[28]  C. Doherty,et al.  The 67 kDa laminin receptor: structure, function and role in disease. , 2008, Bioscience reports.

[29]  A. Rigotti.  Absorption, transport, and tissue delivery of vitamin E. , 2007, Molecular aspects of medicine.

[30]  M. Traber,et al.  Vitamin E, antioxidant and nothing more. , 2007, Free radical biology & medicine.

[31]  W. Stone,et al.  Comparative effects of RRR-alpha- and RRR-gamma-tocopherol on proliferation and apoptosis in human colon cancer cell lines , 2006, BMC Cancer.

[32]  Laxmikant V. Kalé,et al.  Scalable molecular dynamics with NAMD , 2005, J. Comput. Chem..

[33]  Koji Yamada,et al.  A lipid raft-associated 67kDa laminin receptor mediates suppressive effect of epigallocatechin-3-O-gallate on FcepsilonRI expression. , 2005, Biochemical and biophysical research communications.

[34]  I. Mérida,et al.  Importance of chroman ring and tyrosine phosphorylation in the subtype‐specific translocation and activation of diacylglycerol kinase α by d‐α‐tocopherol , 2005 .

[35]  A. Stocker.  Molecular Mechanisms of Vitamin E Transport , 2004, Annals of the New York Academy of Sciences.

[36]  A. Stocker,et al.  Molecular determinants of heritable vitamin E deficiency. , 2004, Biochemistry.

[37]  Y. Fujimura,et al.  A receptor for green tea polyphenol EGCG , 2004, Nature Structural &Molecular Biology.

[38]  Hege S. Beard,et al.  Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. , 2004, Journal of medicinal chemistry.

[39]  W. Hendrickson,et al.  Crystal structure of human α-tocopherol transfer protein bound to its ligand: Implications for ataxia with vitamin E deficiency , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[40]  Nea Malila,et al.  Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. , 2003, JAMA.

[41]  H. Glatt,et al.  Vitamin E activates gene expression via the pregnane X receptor. , 2003, Biochemical pharmacology.

[42]  Lintao Wang,et al.  Probing Protein Structure and Dynamics by Hydrogen Exchange–Mass Spectrometry , 2002, Current protocols in protein science.

[43]  R. Coffey,et al.  Vitamin E succinate is a potent novel antineoplastic agent with high selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) in vivo. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[44]  D. Dormont,et al.  The 37‐kDa/67‐kDa laminin receptor acts as the cell‐surface receptor for the cellular prion protein , 2001, The EMBO journal.

[45]  S. Grundy,et al.  Studies of LDL oxidation following α-, γ-, or δ-tocotrienyl acetate supplementation of hypercholesterolemic humans , 2000 .

[46]  M. Malafa,et al.  Vitamin E succinate promotes breast cancer tumor dormancy. , 2000, The Journal of surgical research.

[47]  M. Topham,et al.  Mammalian Diacylglycerol Kinases, a Family of Lipid Kinases with Signaling Functions* , 1999, The Journal of Biological Chemistry.

[48]  S. Ménard,et al.  Formation of the 67‐kDa laminin receptor by acylation of the precursor , 1998, Journal of cellular biochemistry.

[49]  Hiroyuki Arai,et al.  Affinity for α‐tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs , 1997, FEBS letters.

[50]  G. King,et al.  Prevention of glomerular dysfunction in diabetic rats by treatment with d-alpha-tocopherol. , 1997, Journal of the American Society of Nephrology : JASN.

[51]  E. Campo,et al.  OVEREXPRESSION OF THE 67‐kD LAMININ RECEPTOR CORRELATES WITH TUMOUR PROGRESSION IN HUMAN COLORECTAL CARCINOMA , 1996, The Journal of pathology.

[52]  K Schulten,et al.  VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.

[53]  A. Azzi,et al.  d-alpha-tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[54]  T. Darden,et al.  A smooth particle mesh Ewald method , 1995 .

[55]  B. Brooks,et al.  Constant pressure molecular dynamics simulation: The Langevin piston method , 1995 .

[56]  H. Li,et al.  Analysis of plasma and urinary tea polyphenols in human subjects. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[57]  M. Koenig,et al.  Ataxia with isolated vitamin E deficiency is caused by mutations in the α–tocopherol transfer protein , 1995, Nature Genetics.

[58]  M. Traber,et al.  Absorption, lipoprotein transport, and regulation of plasma concentrations of vitamin E in humans. , 1993, Journal of lipid research.

[59]  J. H. Strauss,et al.  High-affinity laminin receptor is a receptor for Sindbis virus in mammalian cells , 1992, Journal of virology.

[60]  Deborah A. Brown,et al.  Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface , 1992, Cell.

[61]  V. Castronovo,et al.  Functional domains of the 67-kDa laminin receptor precursor. , 1991, The Journal of biological chemistry.

[62]  H. Arai,et al.  Purification and characterization of the α‐tocopherol transfer protein from rat liver , 1991 .

[63]  A. Szewczyk,et al.  Inhibition of cell proliferation by alpha-tocopherol. Role of protein kinase C. , 1991, The Journal of biological chemistry.

[64]  L. Liotta,et al.  Increased expression of the laminin receptor in human colon cancer. , 1991, Journal of the National Cancer Institute.

[65]  L. Liotta,et al.  Expression of laminin receptor in normal and carcinomatous human tissues as defined by a monoclonal antibody. , 1985, Cancer research.

[66]  K. Mark,et al.  Isolation of a laminin‐binding protein from muscle cell membranes , 1983, The EMBO journal.

[67]  M. Wicha,et al.  Isolation of a cell surface receptor protein for laminin from murine fibrosarcoma cells , 1983, The Journal of cell biology.

[68]  L. Liotta,et al.  Isolation of a tumor cell laminin receptor. , 1983, Biochemical and biophysical research communications.

[69]  G. Ciccotti,et al.  Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes , 1977 .

[70]  J. D. Doll,et al.  Generalized Langevin equation approach for atom/solid-surface scattering: General formulation for classical scattering off harmonic solids , 1976 .